Fosfomycin susceptibility among extended-spectrum-β-lactamase-producing Escherichia coli in Nottingham, UK

被引：14
|
作者：
Chislett, R. J. [1 ]
White, G. [1 ]
Hills, T. [2 ]
Turner, D. P. J. [1 ,3 ]
机构：
[1] Univ Nottingham, Hosp NHS Trust, Dept Clin Microbiol, Nottingham NG7 2UH, England
[2] Univ Nottingham, Hosp NHS Trust, Dept Pharm, Nottingham NG7 2UH, England
[3] Univ Nottingham, Ctr Biomol Sci, Inst Infect Immun & Inflammat, Mol Bacteriol & Immunol Grp, Nottingham NG7 2RD, England
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2010年 / 65卷 / 05期
关键词：
Monuril; urinary tract infections; ESBLs; URINARY-TRACT; INFECTIONS; RESISTANT;
D O I：
10.1093/jac/dkq051
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：1076 / 1077
页数：2
相关论文
共 50 条
  • [1] In vitro activity of fosfomycin against extended-spectrum-β-lactamase-producing Escherichia coli and Klebsiella pneumoniae:: Comparison of susceptibility testing procedures
    de Cueto, M
    López, L
    Hernández, JR
    Morillo, C
    Pascual, A
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (01) : 368 - 370
  • [2] Prevalence of extended-spectrum-β-lactamase-producing Escherichia coli from pigs at slaughter in the UK in 2013
    Randall, L. P.
    Lemma, F.
    Rogers, J. P.
    Cheney, T. E. A.
    Powell, L. F.
    Teale, C. J.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (11) : 2947 - 2950
  • [3] Extended-Spectrum-β-Lactamase-Producing Escherichia coli as Intestinal Colonizers in the German Community
    Valenza, Giuseppe
    Nickel, Silke
    Pfeifer, Yvonne
    Eller, Christoph
    Krupa, Elzbieta
    Lehner-Reindl, Verena
    Hoeller, Christiane
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (02) : 1228 - 1230
  • [4] Susceptibility of extended-spectrum- -lactamase-producing Escherichia coli to commercially available and laboratory-isolated bacteriophages
    Fitzgerald-Hughes, Deirdre
    Bolkvadze, Darajen
    Balarjishvili, Nana
    Leshkasheli, Lika
    Ryan, Maia
    Burke, Liam
    Stevens, Niall
    Humphreys, Hilary
    Kutateladze, Mzia
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (04) : 1148 - 1150
  • [5] Change in the prevalence of extended-spectrum-β-lactamase-producing Escherichia coli in Japan by clonal spread
    Suzuki, Satowa
    Shibata, Naohiro
    Yamane, Kunikazu
    Wachino, Jun-ichi
    Ito, Kenitiro
    Arakawa, Yoshichika
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (01) : 72 - 79
  • [6] Treatment with tigecycline of recurrent urosepsis caused by extended-spectrum-β-lactamase-producing Escherichia coli
    Krueger, Wolfgang A.
    Kempf, Volkhard A. J.
    Peiffer, Manou
    Nagele, Udo
    Unertl, Klaus E.
    Schroeder, Torsten H.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (02) : 817 - 820
  • [7] Multidirectional dynamic model for the spread of extended-spectrum-β-lactamase-producing Escherichia coli in the Netherlands
    Costa, Eduardo de Freitas
    Hagenaars, Thomas J.
    Dame-Korevaar, Anita
    Brouwer, Michael S. M.
    de Vos, Clazien J.
    [J]. MICROBIAL RISK ANALYSIS, 2022, 22
  • [8] Extended-spectrum β-lactamase-producing Escherichia coli
    Sloth, Louise B.
    Hargreaves, Sally
    Nellums, Laura B.
    Nielsen, Rikke T.
    Norredam, Marie
    [J]. LANCET INFECTIOUS DISEASES, 2020, 20 (04): : 405 - 405
  • [9] Unacceptably High Error Rates in Vitek 2 Testing of Cefepime Susceptibility in Extended-Spectrum-β-Lactamase-Producing Escherichia coli
    Rhodes, Nathaniel J.
    Richardson, Chad L.
    Heraty, Ryan
    Liu, Jiajun
    Malczynski, Michael
    Qi, Chao
    Scheetz, Marc H.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (07) : 3757 - 3761
  • [10] Duration of Stool Colonization in Healthy Medical Students with Extended-Spectrum-β-Lactamase-Producing Escherichia coli
    Li, Bin
    Zhong, Yang
    Fu, Xiao-chun
    Qiu, Yi-hui
    Wang, Si-Ying
    Yang, A-juan
    Huang, Xin-hong
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (08) : 4558 - 4559
12345